Fed. Circ. Sets Wide Jurisdiction Rule In ANDA Patent Cases
The Federal Circuit ruled Friday that Mylan Inc. must face patent infringement suits over two planned generic drugs in the District of Delaware, holding in a broad ruling that the fact...To view the full article, register now.
Already a subscriber? Click here to view full article